fbpx

Clinical Trials

Helping to improve health care services



Clinical trials are essential to the development of new medical treatments and help determine if new medicines are effective, safe and/or better than the current treatments available.  Clinical trials also help to improve health care services by raising standards of treatment. Australian clinical trials are recognised internationally as providing very high-quality patient care. More information on clinical trials can be found on our Frequently Asked Questions page.

If you or a member of your family would like to be considered for participation in a clinical trial, contact us on (08) 9242 7640, email info@affinityresearch.com.au, or

ONCOLOGY TRIALS


Bladder Cancer

Closed to Recruitment

CHECKMATE-901 Study The purpose of this study is to determine whether an investigational immunotherapy nivolumab in combination with ipilimumab or in combination with standard of care chemotherapy is more effective than standard of care chemotherapy alone in treating patients with previously untreated inoperable or metastatic urothelial cancer. For more information click here.


Kidney Cancer

Active but not Recruiting

Apollo: Trial of the combination of immunotherapy Nivolumab with CBT-101 (an oral c-Met inhibitor) in locally advanced or metastatic renal cell carcinoma who have progressed on previous therapy.  For more information, please click here or phone (08) 9242 7640.

CheckMate-9ER: Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma.  For more information, please click here or phone (08) 9242 7640.


Liver Cancer

Open to Recruitment

EMERALD-2: This is a study to assess the safety and efficacy of Durvalumab alone or in combination with Bevacizumab (Avastin) in Hepatocellular Carcinoma (HCC) patients at high risk of recurrence after curative treatment. For more information, click here or phone (08) 9242 7640. You can register your interest in this study by filling out this form.


Lung Cancer

Not Yet Recruiting

The CONTACT-1 Study: A Study of Atezolizumab (immunotherapy) in combination with Cabozantinib verus Docetaxel (standard chemotherapy) in patients with previously treated metastatic Non-Small Cell Lung Cancer. For more information, please click here or phone (08) 9242 7640.


Metastatic Melanoma

Open to Recruitment

The POLARIS Study: An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis.  For more information, please click here or phone (08) 9242 7640.


NEUROLOGY TRIALS


Myositis

Closed to Recruitment

The IM101-611 Study: This trial is being conducted by Dr Merrilee Needham, Fiona Stanley Hospital.  Affinity Research is providing nursing support for this study. It is a trial to evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy.


GASTROENTEROLOGY TRIALS


Crohn’s Disease

Closed to Recruitment

The SERENITY Study: A Study of Mirikizumab (LY3074828) in Participants With Active Crohn’s Disease.  For more information, please click here or phone (08) 9242 7640.


ALZHEIMER’S DISEASE TRIALS


The AWARE Study

Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer’s Disease. This trial is being conducted by the Australian Alzheimer’s Research Foundation.  Affinity Research is providing nursing support for this study. For more information, please click here or phone (08) 9389 6433 or Email: aarfctd@alzheimers.com.au.


The EMBARK Trial

Active but not Recruiting

221AD304 Phase 3b Study of Aducanumab (BIIB037) in Early Alzheimer’s Disease.  This trial is being conducted by the Australian Alzheimer’s Research Foundation.  Affinity Research is providing nursing support for this study. For more information, please click here or phone (08) 9389 6433 or Email: aarfctd@alzheimers.com.au.


ANAESTHESIOLOGY Trials